The Effect of Platelet-Rich Plasma on Healing Time in Patients Following Pilonidal Sinus Surgery: A Systematic Review

Affiliations

08 August 2022

-

doi: 10.7759/cureus.27777


Abstract

Background: Pilonidal disease (PD) is a debilitating condition characterised by the infection of subcutaneous tissue in the sacrococcygeal area. It is associated with a high risk of recurrence, pain, infection, and purulent discharge. The two main surgical methods of pilonidal sinus disease include excision with primary closure/flap repair or excision of the sinus with healing by secondary intent. Wounds left open to heal by secondary intent remain extremely common due to their association with reduced risk of recurrence, however, it is associated with prolonged healing times. This study aims to determine whether platelet-rich plasma (PRP) reduces healing time in patients post pilonidal sinus surgery with healing by secondary intent compared to simple wound dressings.

Method: Six databases were searched from their date of origin to May 30, 2022 for randomised control trials using predetermined inclusion and exclusion criteria. Only four papers were selected for review as per the Population, Intervention, Comparison, Outcomes and Study design (PICOS) criteria. Critical appraisal was carried out according to the Scottish Intercollegiate Guidelines Network Methodology Checklist for Randomised Control Trials and was assessed for risk of bias according to the Cochrane Handbook for Systematic Review of Interventions. The pooled effect size was calculated using the fixed-effect model. A homogeneity of pooled effect size for the studies was also found (Cochrane Q test, p-value = 0.97 I-square = 0.0%).

Result: Four studies (n = 336) were included in this review. Three of the four studies reported a statistically significant reduction in time taken in healing the wound. The mean difference between the intervention (PRP group) and the control group was 13.01 days, (95% CI 12.15-13.86 days, p < 0.00001). All of the included studies also reported a statistically significant reduction in time taken to return to work/activities of daily living in the treatment group compared to the control group (MD 9.68 days, 95% CI 9.16-10.21 days, p < 0.00001).

Conclusion: This study shows that PRP is effective in reducing healing time and is associated with a significantly shorter period taken to return to work/activities of daily living in patients post pilonidal sinus surgery, which was the primary and secondary outcome investigated in this systematic review, respectively. PRP should routinely be offered to patients undergoing excisional pilonidal sinus surgery for the aforementioned benefits.

Keywords: a systematic review; healing time; pilonidal sinus surgery; platelet-rich plasma/ prp; return to work.

Conflict of interest statement

The authors have declared that no competing interests exist.


Figures


Similar articles

Platelet-Rich Plasma (PRP) for Sacrococcygeal Pilonidal Disease: An Updated Systematic Review and Meta-Analysis.

Brewer CF, Correia IFS, Miranda BH.World J Surg. 2022 Dec;46(12):2910-2918. doi: 10.1007/s00268-022-06711-w. Epub 2022 Sep 5.PMID: 36064868 Review.

Healing by primary versus secondary intention after surgical treatment for pilonidal sinus.

McCallum I, King PM, Bruce J.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006213. doi: 10.1002/14651858.CD006213.pub2.PMID: 17943897 Updated. Review.

Fibrin glue for pilonidal sinus disease.

Lund J, Tou S, Doleman B, Williams JP.Cochrane Database Syst Rev. 2017 Jan 13;1(1):CD011923. doi: 10.1002/14651858.CD011923.pub2.PMID: 28085995 Free PMC article. Review.

Assessment of the effect of platelet rich plasma on the healing of operated sacrococcygeal pilonidal sinus by lay-open technique: a randomized clinical trial.

Gohar MM, Ali RF, Ismail KA, Ismail TA, Nosair NA.BMC Surg. 2020 Sep 22;20(1):212. doi: 10.1186/s12893-020-00865-x.PMID: 32962673 Free PMC article. Clinical Trial.

Healing by primary versus secondary intention after surgical treatment for pilonidal sinus.

Al-Khamis A, McCallum I, King PM, Bruce J.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD006213. doi: 10.1002/14651858.CD006213.pub3.PMID: 20091589 Free PMC article. Review.


Cited by

Effects of Insular Cortex on Post-Stroke Dysphagia: A Systematic Review and Meta Analysis.

Qiao J, Wu Z, Cheng X, Ye Q, Dai M, Dai Y, Dou Z.Brain Sci. 2022 Oct 2;12(10):1334. doi: 10.3390/brainsci12101334.PMID: 36291268 Free PMC article. Review.


KMEL References


References

  1.  
    1. Negative pressure wound therapy for recurrent pilonidal disease: a review of the literature. Farrell D, Murphy S. J Wound Ostomy Continence Nurs. 2011;38:373–378. - PubMed
  2.  
    1. Global gender differences in pilonidal sinus disease: a random-effects meta-analysis. Luedi MM, Schober P, Stauffer VK, Diekmann M, Doll D. World J Surg. 2020;44:3702–3709. - PubMed
  3.  
    1. Disease that should be remembered: sacrococcygeal pilonidal sinus disease and short history. Kanat BH, Sözen S. World J Clin Cases. 2015;3:876–879. - PMC - PubMed
  4.  
    1. Patient characteristics and symptoms in chronic pilonidal sinus disease. Søndenaa K, Andersen E, Nesvik I, Søreide JA. Int J Colorectal Dis. 1995;10:39–42. - PubMed
  5.  
    1. Evaluation and management of pilonidal disease. Humphries AE, Duncan JE. Surg Clin North Am. 2010;90:113–124. - PubMed
  6.  
    1. Pilo-nidal sinus. Hodges RM. Boston Med Surg J. 1880;103:485–486.
  7.  
    1. Pathology of the postanal pilonidal sinus; its bearing on treatment. Patey DH, Scarff RW. Lancet. 1946;5:484–486. - PubMed
  8.  
    1. Treatment of malignancy arising in pilonidal disease. De Bree E, Zoetmulder FAN, Christodoulakis M, et al. Ann Surg Oncol. 8:60–64. - PubMed
  9.  
    1. Pilonidal sinus disease: early surgery and the limberg flap improve patient outcomes. Editorial Editorial. Adv Skin Wound Care. 2021;34:63. - PubMed
  10.  
    1. Healing by primary closure versus open healing after surgery for pilonidal sinus: systematic review and meta-analysis. McCallum IJ, King PM, Bruce J. BMJ. 2008;336:868–871. - PMC - PubMed
  11.  
    1. Influence of the application of platelet-enriched plasma in oral mucosal wound healing. Lindeboom JA, Mathura KR, Aartman IH, Kroon FH, Milstein DM, Ince C. Clin Oral Implants Res. 2007;18:133–139. - PubMed
  12.  
    1. Platelet-rich plasma mixed-fat grafting: a reasonable prosurvival strategy for fat grafts? Serra-Mestre JM, Serra-Renom JM, Martinez L, Almadori A, D'Andrea F. Aesthetic Plast Surg. 2014;38:1041–1049. - PubMed
  13.  
    1. Evaluation of wound healing in diabetic foot ulcer using platelet-rich plasma gel: a single-arm clinical trial. Mohammadi MH, Molavi B, Mohammadi S, et al. Transfus Apher Sci. 2017;56:160–164. - PubMed
  14.  
    1. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Ferrara N, Henzel WJ. Biochem Biophys Res Commun. 1989;161:851–858. - PubMed
  15.  
    1. A new simplified technique for producing platelet-rich plasma: a short technical note. Marlovits S, Mousavi M, Gäbler C, Erdös J, Vécsei V. Eur Spine J. 2004;13:0–6. - PMC - PubMed
  16.  
    1. Investigating the effect of autologous platelet-rich plasma on pain in patients with pilonidal abscess treated with surgical removal of extensive tissue. Bahar MM, Akbarian MA, Azadmand A. Iran Red Cres Med J. 2013;15:0. - PMC - PubMed
  17.  
    1. Assessment of the effect of platelet rich plasma on the healing of operated sacrococcygeal pilonidal sinus by lay-open technique: a randomized clinical trial. Gohar MM, Ali RF, Ismail KA, Ismail TA, Nosair NA. BMC Surg. 2020;20:212. - PMC - PubMed
  18.  
    1. Evaluation of platelet-rich plasma gel potential in acceleration of wound healing duration in patients underwent pilonidal sinus surgery: a randomized controlled parallel clinical trial. Mohammadi S, Nasiri S, Mohammadi MH, et al. Transfus Apher Sci. 2017;56:226–232. - PubMed
  19.  
    1. The role of the platelet-rich plasma in accelerating the wound-healing process and recovery in patients being operated for pilonidal sinus disease: preliminary results. Spyridakis M, Christodoulidis G, Chatzitheofilou C, Symeonidis D, Tepetes K. World J Surg. 2009;33:1764–1769. - PubMed
  20.  
    1. Scottish Intercollegiate Guidelines Network. SIGN methodology checklist for randomised controlled trials. [ May; 2022 ];https://www.sign.ac.uk/what-we-do/methodology/checklists/. 2020
  21.  
    1. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions, 2nd Edition. Chichester: John Wiley & Sons; 2019. - PubMed